TS

Tapsi Sethi

Active Director Director DIN 10177347
DIN 10177347 First appointment May 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Tapsi Sethi

Data last updated:

Tapsi Sethi is a Director at Fair Ford Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Fair Ford Pharmaceuticals Private Limited reported revenue of ₹15.50 Cr (FY 2025).

DIN 10177347
Primary Designation Director
Industry Paper
First Appointment 26 May 2023
Oldest Company Age 3 yrs
Largest company Fair Ford Pharmaceuticals Private Limited · ₹15.50 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 May 20232023₹15.50 Cr (FY 2025)Active

Board colleagues of Tapsi Sethi

Directorship timeline

Open interactive timeline →
Fair Ford Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Tapsi Sethi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tapsi Sethi

Tapsi Sethi currently holds 1 directorship: Fair Ford Pharmaceuticals Private Limited (Director, since 26 May 2023, revenue ₹15.50 Cr (FY 2025)).

Tapsi Sethi was first appointed on 26 May 2023 as Director at Fair Ford Pharmaceuticals Private Limited.

The current boards of Tapsi Sethi's companies include Nishit Sethi (Fair Ford Pharmaceuticals Private Limited), Rohit Khanduja (Fair Ford Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available